The Seattle Times

1 of 2
Rebecca Droke / Pittsburgh Post-Gazette

Friday, April 25, 2014

Drug that slows fatal disorder inches toward FDA approval

Billy Ellsworth works on social-studies lessons at home in Coraopolis, Pa. He is part of a clinical trial for eteplirsen, a drug that has not only slowed the progression of Duchenne muscular dystrophy, but also improved his symptoms.